or
forgot password

    • cancer clinical trials in eugene, OR

    • Prialt (Ziconotide) In Severe Chronic Pain
    Pain Consultants of Oregon
    Eugene, Oregon 97401
    Pain
    A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

    Eugene, Oregon
    Liposarcoma, Leiomyosarcoma, Neoplasms, Connective and Soft Tissue, Neoplasms, Adipose Tissue, Neoplasms, Muscle Tissue, Neoplasms by Histologic Type, Sarcoma
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Carcinoma, Renal Cell, Kidney Neoplasms
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Chronic Lymphocytic Leukemia
    A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Gastrointestinal Stromal Tumor
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Pain Consultants of Oregon
    Eugene, Oregon 97401
    Pain
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Eugene, Oregon
    Breast Neoplasms, Neoplasm Metastasis
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Carcinoma, Non-Small-Cell Lung
    Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Non Small Cell Lung Cancer
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Colorectal Neoplasms
    Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
    Oregon Urology Specialists
    Eugene, Oregon 97401
    Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia
    Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Lymphoma
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Oregon Urology Specialists
    Eugene, Oregon 97401
    Prostate Cancer, Osteoporosis, Fractures
    Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Osteoporosis
    Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Endometrial Hyperplasia, Osteoporosis
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Colorectal Cancer Metastatic
    A Long-term Safety Study of Infliximab (Remicade)

    Eugene, Oregon
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Willamette Valley Cancer Center

    Trial Locations
    Willamette Valley Cancer Center
    Oncology Associates of Oregon, PC/Willaimette Valley Cancer Center
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Willamette Vallejy Cancer Center
    Eugene, Oregon 97401
    Metastatic Breast Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Willamette Valley Cancer Center - Eugene
    Eugene, Oregon 97401
    Brain and Central Nervous System Tumors
    Telephone and Web-based Teen Tobacco Cessation in HMOs
    Oregon Research Institute
    Eugene, Oregon 97403
    Tobacco Use
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Small Cell Lung Cancer
    Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Small Cell Lung Cancer
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Small Cell Lung Cancer
    Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
    Oregon Research Institute
    Eugene, Oregon 97403
    Smokeless Tobacco Use
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Oregon Medical Group - Clinical Research
    Eugene, Oregon 97401
    Atrial Fibrillation, Atrial Flutter
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Advanced HIV Infection
    An Study of Patients With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Patients Who Take R-CHOP Only
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Lymphoma
    Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
    Site Facility
    Eugene, Oregon 97401
    Hypoactive Sexual Desire Disorder
    Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Carcinoma, Pancreatic Ductal